HomeNewsBusinessPharmEasy to merge with Medlife, could be valued at $1.2 billion

PharmEasy to merge with Medlife, could be valued at $1.2 billion

Medlife and its promoters will get a 19.59 percent stake in PharmEasy's parent company API Holdings for about $230 million, while PharmEasy holds the remaining 80 percent stake.

August 18, 2020 / 22:31 IST
Story continues below Advertisement


Online pharmacy PharmEasy has formally filed with the Competition Commission of India (CCI) seeking approval for the merger with its smaller rival Medlife, documents show.

Medlife and its promoters will get a 19.59 percent stake in PharmEasy's parent company API Holdings for about $230 million, while PharmEasy holds the remaining 80 percent stake. This would value PharmEasy's parent at $1.2 billion, making it the largest player in the space so far.

Story continues below Advertisement

Moneycontrol first reported on July 21 that PharmEasy has been in talks to acquire Medlife for about $200 million, after Medlife was unable to raise external funds from investors.

Founded by Tushar Kumar and Prashant Singh in 2014, Medlife provides medicines, health products, doctor consultations and tests on its website and app. It has not raised any external venture funding so far--an anomaly in the sector--and has been supported by co-founder Kumar’s trust.